Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis

This publication has 13 references indexed in Scilit:

• p53 and p21WAF1/CIP1/SDI1 gene products in barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction
  Human Pathology, 1996
• Long term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis
  Cancer, 1994
• The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1994
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
  Cell, 1993
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993
• THE TUMOR SUPPRESSOR GENES
  Annual Review of Biochemistry, 1993
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
  Cell, 1992
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
  Proceedings of the National Academy of Sciences, 1991
• Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
  Nature, 1991
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA
  Acta Pathologica Microbiologica Scandinavica, 1965